Articles for : market cap
ECONOMY
Investor Michael Burry Sells GameStop Shares Over $55 Billion eBay Bid Concerns
Short summary
Investor Michael Burry sold all his GameStop stock, citing concerns over Ryan Cohen's $55.5 billion bid for eBay and excessive company debt.
United States
ECONOMY
SpaceX IPO could cause EPAM Systems to be removed from S&P 500
Short summary
SpaceX's massive IPO might lead to EPAM Systems being removed from the S&P 500 index, potentially impacting its stock value.
ECONOMY
Le PDG d'Apple démissionne : la nouvelle direction stimulera-t-elle l'IA et l'action ?
Short summary
Le PDG de longue date d'Apple quitte ses fonctions, ce qui soulève des questions sur la future stratégie de l'entreprise en matière d'IA et sur la performance de son action face aux inquiétudes des investisseurs.
TECHNOLOGY
Palantir Bets Big on AI Platform to Drive Massive Revenue Growth and Reach Trillion-Dollar Valuation
Short summary
Palantir aims for tenfold revenue growth by 2030, banking on its AI platform to power enterprises. This strategy could drive its market value to $1 trillion.
United States
TECHNOLOGY
Eos Energy Director Buys Shares, Signaling Confidence in Company Future
Short summary
Eos Energy's director buys shares, showing confidence amidst mixed market reactions.
TECHNOLOGY
Meta executives aim for $9 trillion valuation by 2031
Short summary
Meta Platforms has set an ambitious goal for executives to reach a $9 trillion valuation by 2031, but faces challenges including stock performance and regulatory fines.
ECONOMY
AST SpaceMobile Stock Soars on Ambitious Satellite Broadband Plans Despite High Valuation
Short summary
Investors pay a premium for AST SpaceMobile's direct-to-smartphone satellite broadband promise, despite significant execution risk and a soaring valuation.
United States
ECONOMY
Bitcoin slips below $67,000 as investors pivot away from risk‑on assets
Short summary
The dip follows a shift toward tech‑stock correlation and reduced ETF exposure, prompting analysts to warn of continued volatility and thin order books.
HEALTH
Amgen's MariTide: A Potential GLP-1 Rival to Eli Lilly's Blockbusters
Short summary
Amgen’s MariTide, a monthly injectable GLP-1 drug, could challenge Eli Lilly’s dominance, offering a convenient alternative for weight loss and diabetes.